Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-160802
Filing Date
2017-05-05
Accepted
2017-05-05 16:06:07
Documents
8
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d374977d10ka.htm 10-K/A 34585
2 EX-10.27 d374977dex1027.htm EX-10.27 143576
3 EX-10.28 d374977dex1028.htm EX-10.28 144199
4 EX-10.29 d374977dex1029.htm EX-10.29 289089
5 EX-31.1 d374977dex311.htm EX-31.1 9050
6 EX-31.2 d374977dex312.htm EX-31.2 9065
7 EX-32.1 d374977dex321.htm EX-32.1 4071
8 EX-32.2 d374977dex322.htm EX-32.2 4088
  Complete submission text file 0001193125-17-160802.txt   638931
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36066 | Film No.: 17818401
SIC: 2834 Pharmaceutical Preparations